AOCI at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.
The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zevra Therapeutics, Inc.'s aoci.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Zevra Therapeutics, Inc.'s AOCI?
- Zevra Therapeutics, Inc. (ZVRA) reported AOCI of -$1.8M in Q1 2026.
- How has Zevra Therapeutics, Inc.'s AOCI changed year-over-year?
- Zevra Therapeutics, Inc.'s AOCI decreased by 2091.5% year-over-year, from -$82K to -$1.8M.
- What does AOCI mean?
- Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.